Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis
Scripta Medica · 2026 · 57 (3) · 547-555
DOI: 10.5937/scriptamed57-65514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scripta Medica, 2026. Verfasst von Heba Amer und 4 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aim: Hepatocellular carcinoma (HCC) is considered the 6th prevalent tumour and 3rd leading cause of cancer-associated mortality worldwide. Protein kinase C delta (PKCδ), released by liver cancer cells, has an effect in cell-proliferation and cancer formation, recommending PKCδ can serve as a good biomarker in HCC detection. The aim of this research was the assessment of predictive value of PKCδ as a diagnostic biomarker for HCC in hepatitis C virus (HCV)-related cirrhosis.
Methods
The study involved 180 participants, who were separated into three groups, the first control group included 45 healthy volunteers, the second cirrhotic without HCC group (non-HCC group) included 45 cirrhotic patients due to HCV and the third cirrhotic with HCC group (HCC group) included 90 cases with HCC on top of HCV-related cirrhosis. All participants were subjected to clinical examination, taking of history, radiological evaluation and routine laboratory investigations involving Alpha-fetoprotein (AFP) assessment. PKCδ was assessed for all participants using Enzyme-Linked Immunosorbent Assay.
Results
AFP and PKCδ concentrations were greater in HCC than in non-HCC and controls. PKCδ ≥ 30.75 ng/mL showed excellent diagnostic performance for detecting HCC in HCV-related cirrhosis (AUC = 0.977, sensitivity 95.6 %, specificity 86.7 %, accuracy 92.6 %). Multivariate analysis identified PKCδ ≥ 30.75 ng/mL, AFP ≥ 9.4 ng/mL and current smoking as independent predictors of HCC.
Conclusion
PKCδ has a significant diagnostic ability for hepatocellular carcinoma (HCC), with good specificity and sensitivity in HCC prediction in patients with HCV-related liver cirrhosis.
Zitieren
APA
Amer, H., Elfakhry, A., Abd, E., El, A., & Abozeid, F. (2026). Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis. Scripta Medica, 57(3), 547-555. https://doi.org/10.5937/scriptamed57-65514
Vancouver
Amer H, Elfakhry A, Abd E, El A, Abozeid F. Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis. Scripta Medica. 2026;57(3):547-555. doi:10.5937/scriptamed57-65514
BibTeX
@article{Amer2026,
author = {Amer, Heba and Elfakhry, A. and Abd, El-Hafez and El, Arman and Abozeid, Fatma},
title = {Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis},
journal = {Scripta Medica},
year = {2026},
volume = {57},
number = {3},
pages = {547--555},
doi = {10.5937/scriptamed57-65514}
}
EUVIMED